Mark Murphy

City:

Allschwil

Country:

Switzerland

Published Applications:

Last publication date:

2023-06-22

Top Assignees for applications by Mark Murphy

The entities that hold a legal rights for patent applications filed by inventor Murphy Mark:

Actelion Pharmaceuticals Ltd. 2 Allschwil, Switzerland
IDORSIA PHARMACEUTICALS LTD 2 Allschwil, Switzerland

Recent patent applications by Murphy Mark

Mark Murphy from Allschwil, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-06-22

US20230192708A1

Chemistry; metallurgy

2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES

#2 | 2022-08-25

US20220265658A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A TETRAHYDROPYRAZOLOPYRIMIDINONE COMPOUND

#3 | 2020-11-26

US20200369672A1

Chemistry; metallurgy

Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators

#4 | 2020-11-05

US20200347029A1

Chemistry; metallurgy

C5A receptor modulators

#5 | 2014-06-12

US20140163035A1

Chemistry; metallurgy

Heterocyclic amide derivatives as P2X7 receptor antagonists

#6 | 2014-03-13

US20140073651A1

Chemistry; metallurgy

BENZAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

InventorID:

687106 ⎘